Vanguard (UAMY) amendment lists 0 shares after internal realignment
Rhea-AI Filing Summary
United States Antimony Corp Schedule 13G/A: The Vanguard Group reports 0 shares beneficially owned, representing 0% of the common stock. The amendment explains an internal realignment effective January 12, 2026, under SEC Release No. 34-39538, causing certain Vanguard subsidiaries or business divisions to report separately. The filing is signed by Ashley Grim, Head of Global Fund Administration, dated 03/27/2026.
Positive
- None.
Negative
- None.
Insights
Vanguard disaggregated holdings and reports zero beneficial ownership in UAMY here.
The filing states 0 shares and 0% ownership explicitly and cites an internal reorganization under SEC Release No. 34-39538. This reflects reporting treatment changes by Vanguard rather than a market trade or disposal.
Cash‑flow treatment and any previous holdings are not stated; subsequent filings from Vanguard or the company may show the reallocated holder reporting amounts.
Amendment follows SEC guidance allowing disaggregation of former central holdings.
The note explains subsidiaries/business divisions will report separately in reliance on the cited release. That language aligns with routine reallocation of reporting responsibilities under SEC precedent and does not assert misconduct.
Investors should track later 13G/A entries for the specific subsidiary reports if they need holder-level positions.
FAQ
What does The Vanguard Group report for UAMY ownership?
Why does Vanguard say subsidiaries will report separately in this filing?
Who signed the Schedule 13G/A and when was it signed?
Does this filing indicate Vanguard sold or bought UAMY shares?
Will other Vanguard entities now report any UAMY holdings?